Calithera Biosciences, Inc.
CALA
$0.0001
$0.000.00%
OTC PK
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 25.45M | 34.07M | 41.79M | 44.66M | 59.54M |
| Total Receivables | -- | -- | -- | 127.00K | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.17M | 629.00K | 1.04M | 2.48M | 1.92M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 26.62M | 34.70M | 42.82M | 47.27M | 61.45M |
|
|
|||||
| Total Current Assets | 26.62M | 34.70M | 42.82M | 47.27M | 61.45M |
| Net Property, Plant & Equipment | 1.78M | 2.12M | 2.46M | 2.70M | 3.03M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 270.00K | 270.00K | 270.00K | 270.00K | 270.00K |
| Total Assets | 28.68M | 37.08M | 45.56M | 50.24M | 64.76M |
|
|
|||||
| Total Accounts Payable | 732.00K | 1.01M | 990.00K | 2.12M | 3.65M |
| Total Accrued Expenses | 4.94M | 6.15M | 6.35M | 7.33M | 8.94M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.53M | 1.49M | 1.45M | 1.41M | 1.37M |
| Total Finance Division Other Current Liabilities | 193.00K | 583.00K | 107.00K | 514.00K | 45.00K |
| Total Other Current Liabilities | 193.00K | 583.00K | 107.00K | 514.00K | 45.00K |
| Total Current Liabilities | 7.39M | 9.23M | 8.89M | 11.38M | 14.01M |
|
|
|||||
| Total Current Liabilities | 7.39M | 9.23M | 8.89M | 11.38M | 14.01M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 136.00K | 533.00K | 917.00K | 1.30M | 1.67M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 758.00K | 930.00K | 496.00K | -- | -- |
| Total Liabilities | 8.28M | 10.70M | 10.31M | 12.67M | 15.67M |
|
|
|||||
| Common Stock & APIC | 510.67M | 509.73M | 508.79M | 502.03M | 499.71M |
| Retained Earnings | -512.62M | -505.68M | -495.88M | -505.16M | -491.33M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -1.95M | 4.05M | 12.91M | -3.14M | 8.38M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 22.34M | 22.34M | 22.34M | 40.70M | 40.70M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 22.34M | 22.34M | 22.34M | 40.70M | 40.70M |
|
|
|||||
| Total Common Equity | -1.95M | 4.05M | 12.91M | -3.14M | 8.38M |
| Total Preferred Equity | 22.34M | 22.34M | 22.34M | 40.70M | 40.70M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 20.39M | 26.39M | 35.25M | 37.57M | 49.08M |
|
|
|||||